Skip to main content
Clinical Trials/NL-OMON49098
NL-OMON49098WithdrawnNot Applicable

Physiological effect of the addition of CPAP on top of optimal oxygen supplementation on oxygenation and work of breathing in COVID-19 patients - CPAP in COVID-19

niversitair Medisch Centrum Groningen0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - > 18 years of age
  • - proven COVID-19 positive disease
  • - being admitted to the hospital with oxygenation problems, needing oxygen *
  • - Patients need to be able to read and understand the patient information
  • letter and sign informed consent.

Exclusion Criteria

  • * Patients with severe comorbid pulmonary disease or other diseases leading to
  • hypercapnic respiratory failure
  • * * Patients in instable condition (hypotensive, cardiac failure/arrhythmia,
  • more than 1 organ failure, upper airway obstruction, very high work of
  • breathing (breathing frequency at rest persistently > 30 breaths/min)
  • * Unable to fit mask
  • * Patients who are vomiting
  • * Agitated, uncooperative patients
  • * Patients who are unable to protect their airway (for example swallowing
  • impairment)
  • * Patients with excessive secretions that cannot be managed adequately
  • * Patients with recent upper airway of upper gastro-intestinal surgery
  • * Patients with severe skin disease making attachment of the ExG skin
  • electrodes impossible
  • * Pregnant patients
  • * Patients not being able to read and understand the patient information
  • letter and sign informed consent.

Investigators

Similar Trials